You can now register for the 2018 CADTH Symposium! To ensure a balanced mix of attendees, we use a two-step registration process.
Step 1: Request to Register — Click on the “Request to Register” link and complete the form
Step 2: Complete Your Registration — Our Event Managers will send you the…
A draft report on Dental Amalgams Compared With Resin Composites is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Dental Amalgams Compared With Resin Composites
2018-01-31
2018-02-14
Consultation Document
Product Type
Submit Stakeholder…
In 2017, CADTH began preliminary work on a Therapeutic Review to assess new third-line drug therapies for type 2 diabetes and provide recommendations on their optimal use. The drugs included in this review included dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 analogues, and sodium-…
A draft report on Optimal Strategies for the Diagnosis of Acute Pulmonary Embolism is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Optimal Strategies for the Diagnosis of Acute Pulmonary Embolism
2018-01-22
2018-02-06
Consultation Document…
A draft report on Canadian Medical Imaging Inventory (CMII) is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Canadian Medical Imaging Inventory (CMII)
2018-01-19
2018-02-02
Consultation Document
Product Type
Submit Stakeholder Feedback…
A draft report on Public Dental Programs and Reimbursement for Dental Restorative Procedures is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Public Dental Programs and Reimbursement for Dental Restorative Procedures
2018-01-22
2018-02-05…
Given the theme of the 2018 CADTH Symposium ― Managing Health Technologies: Supporting Appropriate, Affordable, and Accessible Care ― which relates so directly to patients, CADTH is very pleased that our conference is once again officially accredited by Patients Included.
The annual CADTH Symposium…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
A Statement from Dr. Brian O’Rourke, President and CEO
In November 2016 I represented CADTH at the two-day Opioid Summit, joining many others to discuss Canada’s response to the escalating opioid crisis and make a formal commitment to the Joint Statement of Action to Address the Opioid Crisis.
I…
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.